Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CPIX
CPIX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CPIX News
RedHill Biopharma Completes Private Placement Financing
2d ago
PRnewswire
FDA Grants Rare Pediatric Disease Designation to Opaganib for Neuroblastoma Treatment
Jun 09 2026
PRnewswire
FDA Grants Rare Pediatric Disease Designation to Opaganib for Neuroblastoma
Jun 09 2026
Newsfilter
RedHill Biopharma Initiates Enforcement Proceedings in Korea
Jun 08 2026
PRnewswire
Ifetroban Shows Positive Results in Phase 2a Trial for High-Risk Tumors
Jun 02 2026
PRnewswire
Cumberland Pharmaceuticals Reports Positive Phase 2a Trial Results for Ifetroban
Jun 02 2026
Newsfilter
RedHill Biopharma Advances Opaganib for EVD Treatment Amid Outbreak
Jun 02 2026
PRnewswire
Cumberland Pharmaceuticals Launches Vibativ in China Through SciClone Partnership
May 28 2026
PRnewswire
Cumberland Pharmaceuticals Launches Antibiotic in China Through SciClone Partnership
May 28 2026
Newsfilter
Cumberland Pharmaceuticals Q1 2026 Earnings Call Insights
May 06 2026
seekingalpha
CUMBERLAND PHARMACEUTICALS REPORTS Q1 ADJUSTED EPS OF USD -0.13
May 05 2026
moomoo
Cumberland Pharmaceuticals Reports Q1 Revenue of $9.1 Million
May 05 2026
moomoo
Cumberland Pharmaceuticals Strategic Transaction Unlocks $100 Million in Value
May 05 2026
PRnewswire
Cumberland Pharmaceuticals Strategic Transaction Unlocks $100 Million in Value
May 05 2026
Newsfilter
RedHill's RHB-204 Shows Promising Phase 2 Results for Crohn's Disease
Apr 30 2026
PRnewswire
Cumberland Receives FDA Approval for Expanded Indication of Caldolor
Apr 16 2026
PRnewswire
Show More News
